Metabolomics predicts the pharmacological profile of new psychoactive substances.

Eulalia OlestiIlario De TomaJohannes G RamaekersTibor M BruntMarcel Lí CarbóCristina Fernández-AvilésPatricia RobledoMagí FarréMara DierssenÓscar J PozoRafael de la Torre

Published in: Journal of psychopharmacology (Oxford, England) (2018)

Our approach allows a fast NPS pharmacological classification which will benefit both drug risk evaluation policies and public health.

Keyphrases

public health
machine learning
deep learning
mass spectrometry
global health
drinking water
emergency department
adverse drug